Last Price
2.31
Today's Change
+0.21 (10.00%)
Day's Change
2.11 - 2.33
Trading Volume
91,044
Market Cap
80 Million
Shares Outstanding
34 Million
Avg Volume
165,028
Avg Price (50 Days)
2.73
Avg Price (200 Days)
5.66
PE Ratio
-4.20
EPS
-0.55
Earnings Announcement
26-Feb-2025
Previous Close
2.10
Open
2.11
Day's Range
2.11 - 2.33
Year Range
1.078 - 46.0
Trading Volume
91,044
1 Day Change
10.00%
5 Day Change
13.79%
1 Month Change
-6.48%
3 Month Change
-26.43%
6 Month Change
-48.55%
Ytd Change
-92.06%
1 Year Change
-92.06%
3 Year Change
-92.06%
5 Year Change
-92.06%
10 Year Change
-92.06%
Max Change
-92.06%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
FibroBiologics, Inc., a clinical-stage cell therapy company, develops and commercializes fibroblast-based therapies in the United States. It is developing CybroCell, for the treatment of degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for wound healing. The company is also on the early-stage research of CYTER915, which is designed to regenerate or reinvigorate production of the thymus and/or spleen; CYPS317, for the treatment of psoriasis; and TCB190 to treat certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.